The adoptive transfer of tumor-infiltrating lymphocytes (TILs) of metastatic melanoma in
humans. The genes encoding the antigens recognized by these TILs have been cloned and
characterized. Here, Steven Rosenberg review's how these genes and gene products are
being used to develop new immunotherapies for the treatment of patients with cancer.